Search

Your search keyword '"Elif I. Ekinci"' showing total 208 results

Search Constraints

Start Over You searched for: Author "Elif I. Ekinci" Remove constraint Author: "Elif I. Ekinci"
208 results on '"Elif I. Ekinci"'

Search Results

1. Glucagon‐like peptide‐1 receptor agonists and kidney outcomes

2. A pilot randomised controlled parallel arm trial evaluating treatment satisfaction with the Omnipod DASH® Insulin Management System compared with usual care in adults with type 1 diabetes in Australia: rationale, study design and methodologies

Catalog

Books, media, physical & digital resources

3. A systematic review: Cost‐effectiveness of continuous glucose monitoring compared to self‐monitoring of blood glucose in type 1 diabetes

4. The prevalence of sarcopenia in middle‐aged and older patients in post‐acute inpatient rehabilitation: a cross‐sectional study

5. Testing for monogenic diabetes is lower than required to reveal its true prevalence in an Australian population

6. Efficacy of Flash Glucose Monitoring in Type 1 and Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomised Controlled Trials

7. Blood Plasma Metabolites in Diabetes-Associated Chronic Kidney Disease: A Focus on Lipid Profiles and Cardiovascular Risk

8. The Association Between Sarcopenia and Functional Improvement in Older and Younger Patients Who Completed Inpatient Rehabilitation: A Prospective Cohort Study

9. Goal attainment scaling outcomes in general inpatient rehabilitation: association with functional independence and perceived goal importance and difficulty

10. Does left ventricular hypertrophy affect cognition and brain structural integrity in type 2 diabetes? Study design and rationale of the Diabetes and Dementia (D2) study

11. Gut Microbiome Composition Remains Stable in Individuals with Diabetes-Related Early to Late Stage Chronic Kidney Disease

12. Potential for Novel Biomarkers in Diabetes-Associated Chronic Kidney Disease: Epigenome, Metabolome, and Gut Microbiome

13. Biomarkers for Macrosomia Prediction in Pregnancies Affected by Diabetes

14. Use of Readily Accessible Inflammatory Markers to Predict Diabetic Kidney Disease

16. Review of Evidence for Adult Diabetic Ketoacidosis Management Protocols

17. Diabetes <scp>IN</scp> hospital – Glucose and Outcomes in the <scp>COVID</scp> ‐19 pandemic ( <scp>DINGO COVID</scp> ‐19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations

18. Feasibility of using a transition diabetes team to commence injectable therapies postdischarge from a tertiary hospital: a pilot, randomised controlled trial

19. Impact of botanical fermented foods on metabolic biomarkers and gut microbiota in adults with metabolic syndrome and type 2 diabetes: a systematic review protocol

20. Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use

21. The impact of botanical fermented foods on obesity, metabolic syndrome and type 2 diabetes: a systematic review of randomised controlled trials

22. Sodium glucose co‐transporter‐2 inhibitor‐induced diabetic ketoacidosis following tooth extraction: improving awareness among dental practitioners

23. Novel Therapies for Kidney Disease in People With Diabetes

24. The ambulatory glucose profile and its interpretation

25. Feasibility trial of metformin XR in people with pre-diabetes and stroke (MIPPS)-randomised open blinded endpoint controlled trial

26. GripBMI – A fast and simple sarcopenia screening tool in post acute inpatient rehabilitation

27. Geometric Distortion Correction of Renal Diffusion Tensor Imaging Using the Reversed Gradient Method

28. Risk factors for pregnancy outcomes in Type 1 and Type 2 diabetes

29. Diabetes IN hospital - Glucose and Outcomes in the COVID-19 pandemic (DINGO COVID-19): the 2020 Melbourne hospital experience prior to novel variants and vaccinations

30. Performance of 4 Creatinine-based Equations in Assessing Glomerular Filtration Rate in Adults with Diabetes

31. The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review

32. Change in emotional eating after bariatric surgery: systematic review and meta-analysis

33. Exploring the Relationship Between Maternal Circulating Hormones and Gestational Weight Gain in Women Without Obesity: A Cross-Sectional Study

34. Evolving Evidence of Diabetic Ketoacidosis in Patients Taking Sodium-Glucose Cotransporter 2 Inhibitors

35. A safety and pharmacodynamics study of temelimab, an antipathogenic human endogenous retrovirus type W envelope monoclonal antibody, in patients with type 1 diabetes

36. Review of potential biomarkers of inflammation and kidney injury in diabetic kidney disease

37. Response to Comment on Hamblin et al. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor-Treated Type 2 Diabetes. Diabetes Care 2021;44:e124-e126

39. Capillary Ketone Concentrations at the Time of Colonoscopy: A Cross-Sectional Study With Implications for SGLT2 Inhibitor–Treated Type 2 Diabetes

40. Older People With Type 2 Diabetes-Individualising Management With a Specialised Community Team (OPTIMISE): Perspectives of Participants on Care

41. Role of the adaptive immune system in diabetic kidney disease

42. Complications of Diabetes and Metrics of Glycemic Management Derived From Continuous Glucose Monitoring

43. Functional MRI in assessment of diabetic kidney disease in people with type 1 diabetes

44. The comparative epidemiology and outcomes of hospitalized patients treated with SGLT2 or DPP4 inhibitors

45. Changes in soluble tumor necrosis factor receptor type 1 levels and early renal function decline in patients with diabetes

46. Sodium Intake, Circulating Microvesicles and Cardiovascular Outcomes in Type 2 Diabetes

47. Complement C5a Induces Renal Injury in Diabetic Kidney Disease by Disrupting Mitochondrial Metabolic Agility

48. Metformin: time to review its role and safety in chronic kidney disease

49. Exploration of the shared pathophysiological mechanisms of gestational diabetes and large for gestational age offspring

50. Routine HbA1c among hematology and oncology inpatients: Diabetes-status and hospital-outcomes